Rexgenero appoints Edwin Wagena as Chief Operating Officer

30/03/2015

London, UK.  Rexgenero Ltd appoints Edwin Wagena as Chief Operating Officer with responsibility for clinical development and manufacturing.  Edwin has more than 15 years of experience in pharmaceutical development at Kiadis Pharma B.V., Astellas Pharma and Solvay Pharmaceuticals and is the Regional Vice President for the International Society for Cellular Therapy.

innovative cell therapies
Contact us